ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

Funding opportunities listed.

September 17, 2004

NCI STRAP Grants Aim To Move Research Quickly To Clinical Trials

October 1, 2010